Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 18.6B | 17.4B | 19.0B | 12.0B |
Cost of revenue | 2.6B | 2.5B | 2.7B | 2.3B |
Gross profit | 15.9B | 14.9B | 16.3B | 9.7B |
Operating expense | ||||
Research & development | 4.0B | 4.0B | 3.9B | 3.8B |
Selling general and admin | 2.9B | 3.2B | 1.4B | 2.4B |
Other operating expenses | 187.8M | 206.6M | 169.0M | 150.2M |
Operating income | 8.2B | 7.0B | 10.5B | 2.8B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 56.3M | -18.8M | 0 | 37.6M |
Pretax income | 8.3B | 7.0B | 10.5B | 2.9B |
Tax provision | 1.1B | 657.3M | -6.7B | 56.3M |
Net income | 7.2B | 6.3B | 17.2B | 2.8B |
Basic EPS | 0.4 | 0.4 | 1.0 | 0.2 |
Diluted EPS | 0.4 | 0.4 | 1.0 | 0.2 |
Basic average shares | 16.6B | 16.6B | 16.6B | 16.6B |
Diluted average shares | 17.1B | 17.1B | 17.0B | 17.0B |
EBITDA | 8.6B | 7.4B | 10.9B | 3.2B |
Net income from continuing op. | 7.2B | 6.3B | 17.2B | 2.8B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |